Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Change in Cash (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Change in Cash for 16 consecutive years, with -$578540.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 334.06% year-over-year to -$578540.0, compared with a TTM value of -$3.4 million through Oct 2025, up 7.9%, and an annual FY2025 reading of -$3.4 million, up 7.9% over the prior year.
  • Change in Cash was -$578540.0 for Q4 2025 at Pharma-Bio Serv, down from $1.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $7.6 million in Q4 2023 and bottomed at -$7.2 million in Q1 2023.
  • Average Change in Cash over 5 years is -$687935.6, with a median of $235537.0 recorded in 2022.
  • The sharpest move saw Change in Cash plummeted 992.86% in 2021, then surged 3283.86% in 2023.
  • Year by year, Change in Cash stood at $970175.0 in 2021, then tumbled by 76.92% to $223900.0 in 2022, then soared by 3283.86% to $7.6 million in 2023, then plummeted by 96.74% to $247174.0 in 2024, then crashed by 334.06% to -$578540.0 in 2025.
  • Business Quant data shows Change in Cash for PBSV at -$578540.0 in Q4 2025, $1.9 million in Q3 2025, and -$5.2 million in Q2 2025.